183 related articles for article (PubMed ID: 8447550)
1. Lingual hemorrhage in a patient with hemophilia A complicated by a high titer inhibitor. Management by continuous infusion of monoclonal antibody-purified factor VIII.
Gordon EM; Mungo R; Goldsmith JC
Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):107-10. PubMed ID: 8447550
[TBL] [Abstract][Full Text] [Related]
2. Continuous infusion of monoclonal antibody-purified factor VIII: rational approach to serious hemorrhage in patients with allo-/autoantibodies to factor VIII.
Gordon EM; al-Batniji F; Goldsmith JC
Am J Hematol; 1994 Feb; 45(2):142-5. PubMed ID: 8141119
[TBL] [Abstract][Full Text] [Related]
3. A continuing challenge: treatment of hemophilic children with acquired factor VIII inhibitors.
Bell BA
Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):105-6. PubMed ID: 8447549
[No Abstract] [Full Text] [Related]
4. Elective cardiac operation in a patient with severe hemophilia and acquired factor VIII antibodies.
Leggett PL; Doyle D; Smith WB; Culpepper W; Cooper S; Ochsner JL
J Thorac Cardiovasc Surg; 1984 Apr; 87(4):556-60. PubMed ID: 6423912
[TBL] [Abstract][Full Text] [Related]
5. Inhibitor antibodies to factor VIII and factor IX: management.
Lusher JM
Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
[TBL] [Abstract][Full Text] [Related]
6. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
[TBL] [Abstract][Full Text] [Related]
7. Continuous infusion of monoclonal antibody-purified factor VIII.
Weinstein RE; Bona RD; Rickles FR
Am J Hematol; 1991 Mar; 36(3):211-2. PubMed ID: 1899966
[TBL] [Abstract][Full Text] [Related]
8. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
Shima M; Sawamoto Y; Kamisue M; Shibata Y; Tuzi S; Kuwabara M; Tanaka I; Tanizawa T; Tanaka A; Ueda M; Kakishita E; Yoshioka A
Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666
[TBL] [Abstract][Full Text] [Related]
9. Treatment of severe bleeding in hemophilia A with factor VIII inhibitor.
Mahasandana C; Suvatte V; Tanphaichitr VS; Bejrachandra S; Chandanayingyong D
J Med Assoc Thai; 1988 Mar; 71(3):154-8. PubMed ID: 3133440
[No Abstract] [Full Text] [Related]
10. Hemophilia. Strategies for the treatment of inhibitor patients.
Ingerslev J
Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
[TBL] [Abstract][Full Text] [Related]
11. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
[TBL] [Abstract][Full Text] [Related]
12. Management of factor VIII inhibitors.
Dimichele DM
Int J Hematol; 2006 Feb; 83(2):119-25. PubMed ID: 16513529
[TBL] [Abstract][Full Text] [Related]
13. Characterization of an antibody to factor VIII in a patient with acquired hemophilia with circulating immune complexes.
Ly B; Michaelsen TE; Dahl O; Frøland SS
Scand J Haematol; 1982 Feb; 28(2):132-40. PubMed ID: 6806894
[TBL] [Abstract][Full Text] [Related]
14. The use of continuous infusion of factor concentrates in the treatment of hemophilia.
Bona RD; Weinstein RA; Weisman SJ; Bartolomeo A; Rickles FR
Am J Hematol; 1989 Sep; 32(1):8-13. PubMed ID: 2502914
[TBL] [Abstract][Full Text] [Related]
15. Treatment of a high titer anti-factor-VIII antibody by continuous factor VIII administration: report of a case.
White GC; Taylor RE; Blatt PM; Roberts HR
Blood; 1983 Jul; 62(1):141-5. PubMed ID: 6407545
[TBL] [Abstract][Full Text] [Related]
16. Loss of tolerance to exogenous and endogenous factor VIII in a mild hemophilia A patient with an Arg593 to Cys mutation.
Thompson AR; Murphy ME; Liu M; Saenko EL; Healey JF; Lollar P; Scandella D
Blood; 1997 Sep; 90(5):1902-10. PubMed ID: 9292523
[TBL] [Abstract][Full Text] [Related]
17. Acquired hemophilia.
Bouvry P; Recloux P
Haematologica; 1994; 79(6):550-6. PubMed ID: 7896216
[TBL] [Abstract][Full Text] [Related]
18. [Factor VIII epitopes recognized by inhibitors in hemophiliacs].
Hayashi T; Niiya K; Sakuragawa N; Ichihara K; Yamazaki T; Watanabe A
Rinsho Ketsueki; 1991 Sep; 32(9):945-50. PubMed ID: 1719257
[TBL] [Abstract][Full Text] [Related]
19. New protocol for immune tolerance induction in acquired hemophilia.
Nemes L; Pitlik E
Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
[TBL] [Abstract][Full Text] [Related]
20. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
Kubisz P; Plamenová I; Hollý P; Stasko J
Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
